Printer Friendly

Preventing cell death induced by carbonyl stress, oxidative stress or mitochondrial toxins with vitamin B anti-age agents.

Carbonyls generated by autoxidation of carbohydrates or lipid peroxidation have been implicated in advanced glycation end product (AGE) formation in tissues adversely affected by diabetes complications. Tissue AGE and associated pathology have been decreased by vitamin B(1)/B(6) in trials involving diabetic animal models. To understand the molecular cytoprotective mechanisms involved, the effects of B(1)/B(6) vitamers against cytotoxicity induced by AGE/advanced lipid end product (ALE) carbonyl precursors (glyoxal/acrolein) have been compared to cytotoxicity induced by oxidative stress (hydroperoxide) or mitochondrial toxins (cyanide/copper). Thiamin was found to be best at preventing cell death induced by carbonyl stress and mitochondrial toxins but not oxidative stress cell death suggesting that thiamin pyrophosphate restored pyruvate and alphaketoglutarate dehydrogenases inhibited by mitochondrial toxicity. However, B(6) vitamers were most effective at preventing oxidative stress or lipid peroxidation cytotoxicity suggesting that pyridoxal or pyridoxal phosphate were antioxidants and/or Fe/Cu chelators. A therapeutic vitamin cocktail could provide maximal prevention against carbonyl stress toxicity associated with diabetic complications.

Mol Nutr Food Res. 2008 Mar;52(3):379-85
COPYRIGHT 2009 LE Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Pyridoxal-5'-Phosphate
Publication:Life Extension
Article Type:Brief article
Geographic Code:1USA
Date:Jul 1, 2009
Previous Article:Inhibition of crystallin ascorbylation by nucleophilic compounds in the hsvct2 mouse model of lenticular aging.
Next Article:Renoprotective effects of the age-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters